|
Q1 2018
Filed on May 14, 2018
|
2,888
|
$49.76 - $62.28
$144K - $180K
|
|
|
Q1 2018
Filed on May 14, 2018
|
28,000
|
N/A
|
|
|
Q1 2018
Filed on May 14, 2018
|
3,401
|
$55.5 - $66.29
$189K - $225K
|
|
Powershs Db Us Dollar Index
|
Q1 2018
Filed on May 14, 2018
|
9,000
|
N/A
|
|
|
Q1 2018
Filed on May 14, 2018
|
1,750
|
$118.35 - $139.21
$207K - $244K
|
|
|
Q1 2018
Filed on May 14, 2018
|
2,947
|
$62.94 - $79.0
$185K - $233K
|
|
|
Q1 2018
Filed on May 14, 2018
|
1,888
|
$116.63 - $131.53
$220K - $248K
|
|
|
Q1 2018
Filed on May 14, 2018
|
675
|
N/A
|
|
|
Q1 2018
Filed on May 14, 2018
|
3,170
|
$60.36 - $67.05
$191K - $213K
|
|
|
Q1 2018
Filed on May 14, 2018
|
3,507
|
$71.15 - $85.2
$250K - $299K
|
|
|
Q1 2018
Filed on May 14, 2018
|
39,000
|
N/A
|
|
|
Q1 2018
Filed on May 14, 2018
|
2,540
|
N/A
|
|
|
Q1 2018
Filed on May 14, 2018
|
24,273
|
N/A
|
|
|
Q1 2018
Filed on May 14, 2018
|
2,424
|
$108.46 - $150.0
$263K - $364K
|
|
Peregrine Pharmaceuticals In
|
Q1 2018
Filed on May 14, 2018
|
38,299
|
N/A
|
|
Fifth Street Finance Corp
|
Q4 2017
Filed on Feb 12, 2018
|
24,700
|
N/A
|
|
|
Q4 2017
Filed on Feb 12, 2018
|
25,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 12, 2018
|
8,536
|
$58.23 - $63.76
$497K - $544K
|
|
|
Q4 2017
Filed on Feb 12, 2018
|
1,716
|
N/A
|
|
Teva Pharmaceutical Fin LLC
|
Q4 2017
Filed on Feb 12, 2018
|
22,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 12, 2018
|
3,500
|
$41.85 - $69.6
$146K - $244K
|
|
|
Q4 2017
Filed on Feb 12, 2018
|
1,941
|
N/A
|
|
|
Q4 2017
Filed on Feb 12, 2018
|
13,135
|
N/A
|
|
Nuance Communications Inc
|
Q4 2017
Filed on Feb 12, 2018
|
34,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 12, 2018
|
12,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 12, 2018
|
6,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 12, 2018
|
12,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 03, 2017
|
20,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 03, 2017
|
28,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 03, 2017
|
12,970
|
$15.41 - $32.17
$200K - $417K
|
|
|
Q3 2017
Filed on Nov 03, 2017
|
28,000
|
N/A
|
|
Du Pont E I De Nemours & CO
|
Q3 2017
Filed on Nov 03, 2017
|
16,743
|
N/A
|
|
|
Q3 2017
Filed on Nov 03, 2017
|
7,755
|
N/A
|
|
Peregrine Pharmaceuticals In
|
Q3 2017
Filed on Nov 03, 2017
|
580,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 03, 2017
|
4,502
|
N/A
|
|
|
Q3 2017
Filed on Nov 03, 2017
|
11,732
|
N/A
|
|
|
Q3 2017
Filed on Nov 03, 2017
|
21,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 03, 2017
|
11,584
|
$12.18 - $13.96
$141K - $162K
|
|